Mesoblast (ASX:MSB) - Webinar Presentation ********* 4.3K subscribers
4 views 8 Mar 2024Silviu Itescu - CEO - Mesoblast (ASX:MSB) is using its proprietary mesenchymal lineage cell technology platform to develop and commercialise innovative allogeneic cellular medicines to treat complex inflammatory diseases resistant to conventional standard of care.
2024 Here we go again., page-144
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.08 |
Change
-0.010(0.92%) |
Mkt cap ! $1.233B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.12 | $1.08 | $1.513M | 1.381M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 113348 | $1.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.08 | 54842 | 18 |
View Market Depth
| Last trade - 10.59am 18/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.09 |
Change
-0.010 ( 0.16 %) |
||||
| Open | High | Low | Volume | ||
| $1.10 | $1.12 | $1.08 | 269243 | ||
| Last updated 11.18am 18/06/2024 ? | |||||
| MSB (ASX) Chart |
